Form 8-K - Current report:
SEC Accession No. 0001299933-12-002459
Filing Date
2012-11-01
Accepted
2012-11-01 16:57:02
Documents
3
Period of Report
2012-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_46347.htm 8-K 10695
2 EX-99.1 exhibit1.htm EX-99.1 72657
3 GRAPHIC e37228-123061554466520ace_1.jpg GRAPHIC 25545
  Complete submission text file 0001299933-12-002459.txt   119813
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 121174215
SIC: 2834 Pharmaceutical Preparations